Mealey's (July 11, 2022, 2:08 PM EDT) -- SAN FRANCISCO — A federal district court did not err in dismissing a shareholder’s federal securities law claims against medical device maker Align Technology Inc. and certain of its senior executives on allegations that the defendants failed to disclose that the company was experiencing a significant drop in financial growth in sales of its most important product in the Chinese market because none of the defendants’ alleged misstatements or omissions was actionable, a Ninth Circuit U.S. Court of Appeals panel ruled July 7 in affirming....